Halozyme Therapeutics Inc. (HALO)

$ 75.11
   
  • Change Today:
    $1.98
  • 52 Week High: $78.28
  • 52 Week Low: $48.95
  • Currency: US Dollars
  • Shares Issued: 145.30m
  • Volume: 2,684,948
  • Market Cap: $10,914m
  • RiskGrade: 189

HALO Overview

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

HALO Fundamentals

Fundamentals data is not available for this company.

HALO Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 1,675.93 1,089.16 813.00¢ 9.2 0.3 +30% n/a 0.0%
31-Dec-27 1,887.98 1,296.54 955.50¢ 7.9 0.5 +18% n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

HALO ShareCast News

Evotec surges on Halozyme takeover interest 15-Nov-2024 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

HALO Market Data

Currency US Dollars
Share Price $ 75.11
Change Today $ 1.98
% Change 2.71 %
52 Week High $78.28
52 Week Low $48.95
Volume 2,684,948
Shares Issued 145.30m
Market Cap $10,914m
RiskGrade 189

What The Brokers Say

Strong Buy 0
Buy 5
Neutral 2
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 07-Jan-2026

Time Volume / Share Price
16:00 265,688 @ $75.11
15:59 100 @ $75.12
15:59 158 @ $75.11
15:59 100 @ $75.10
15:59 100 @ $75.10

Top of Page